Pharmacology of danazol.
Danazol was found to be an orally active pituitary gonadotrophin inhibitor with weak androgenic activity, lacking oestrogenic and progestational effects, and demonstrated safety in toxicological studies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
Cited by (13)
- Effects of Danazol on the Epididymal Function in Male Langurs (Presbytis Entellus Entellus Dufresne) 2009
- Induction of true precocious puberty by neonatal treatment with danazol in female rats 1993
- The Detection of Danazol and Its Significance in Doping Analysis 1992
- Glucose tolerance and insulin resistance after danazol treatment 1989
- Free testosterone levels during danazol therapy 1983
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity 1982
- Hormonal and Surgical Management of Pelvic Endometriosis 1982
- In Vitro Effect of Danazol on Luteinizing Hormone-Releasing Hormone-Stimulated Luteinizing Hormone Release in Rat Anterior Pituitary Cell Cultures in Vitro * 1981
- Pharmacology and Pharmacokinetics of Danazol 1980
- Hypertension: a complication of danazol therapy 1980
- Myalgia and Elevated Creatine Phosphokinase with Danazol® in Hereditary Angioedema 1979
- A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* 1979
- Danazol and Thyroid Function 1979
Source provenance
- openalex
- last seen: 2026-05-10T10:49:45.548917+00:00